Showing 1 - 8 results of 8 for search 'Zhengtang CHEN', query time: 0.03s Refine Results
  1. 1
    The Advances of Lymphangiogenesis in Lung Cancer

    The Advances of Lymphangiogenesis in Lung Cancer by Zhengtang CHEN, Bo ZHU, Weipeng ZHAO

    Published 2008-04-01
    Get full text
    Article
  2. 2
    Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.

    Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls. by Wenlei Zhuo, Liang Zhang, Bo Zhu, Zhiqun Qiu, Zhengtang Chen

    Published 2012-01-01
    Get full text
    Article
  3. 3
    The expression and significance of indoleamine -2,3 -dioxygenase in non-small cell lung cancer cell

    The expression and significance of indoleamine -2,3 -dioxygenase in non-small cell lung cancer cell by Zhengtang CHEN, Jianteng GU, Yali WANG, Bo ZHU, Qichao XIE, Lingli WANG

    Published 2008-02-01
    Get full text
    Article
  4. 4
    CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.

    CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies. by Wenlei Zhuo, Liang Zhang, Yan Wang, Junjun Ling, Bo Zhu, Zhengtang Chen

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1

    Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1 by Liqin Xia, Feng Li, Jun Qiu, Zhongming Feng, Zihan Xu, Zhengtang Chen, Jianguo Sun

    Published 2020-10-01
    Get full text
    Article
  6. 6
    The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

    The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epider... by Yongdong Feng, Guangkuo Zhu, Song Lang, Ping Hao, Guanghui Li, Fanglin Chen, Wenlei Zhuo, Yuzhong Duan, Anmei Zhang, Zhengtang Chen, Jianguo Sun

    Published 2021-05-01
    Get full text
    Article
  7. 7
    Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients

    Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients by Qiao Yang, Qiao Yang, Mingjing Chen, Jiaoyang Gu, Jiaoyang Gu, Kai Niu, Xianlan Zhao, Linpeng Zheng, Zihan Xu, Yongxin Yu, Feng Li, Lingxin Meng, Zhengtang Chen, Wenlei Zhuo, Luping Zhang, Jianguo Sun

    Published 2021-04-01
    Get full text
    Article
  8. 8
    Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib

    Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib by Bo Yuan, Jun Zhao, Chengzhi Zhou, Xiumei Wang, Bo Zhu, Minglei Zhuo, Xilin Dong, Jiemei Feng, Cuihua Yi, Yunpeng Yang, Hua Zhang, Wangyan Zhou, Zhengtang Chen, Sheng Yang, Xinghao Ai, Kehe Chen, Xuefan Cui, Difa Liu, Chunmei Shi, Wei Wu, Yanjun Zhang, Lianpeng Chang, Jin Li, Rongrong Chen, Shuanying Yang

    Published 2020-05-01
    Get full text
    Article

Search Tools: